Company press releases

Displaying 101 - 108 of 108 results
Released Company Title Industry Topic
04 Aug 2021
07:00 CEST 		ARGENX SE argenx to Present at 2021 Wedbush PacGrow Virtual Healthcare Conference 20103010 Biotechnology Other subject
29 Jul 2021
07:00 CEST 		ARGENX SE argenx Reports Half Year 2021 Financial Results and Provides Second Quarter Business Update 20103010 Biotechnology Other subject
22 Jul 2021
07:00 CEST 		ARGENX SE argenx to Report Half Year 2021 Financial Results and Second Quarter Business Update on July 29, 2021 20103010 Biotechnology Other subject
14 Jul 2021
07:00 CEST 		ARGENX SE argenx to Host Virtual R&D Day on July 20, 2021 20103010 Biotechnology Other subject
17 Jun 2021
00:30 CEST 		ARGENX SE argenx announces publication of Phase 3 ADAPT trial results of efgartigimod for the treatment of generalized myasthenia gravis in The Lancet Neurology 20103010 Biotechnology Other subject
07 Jun 2021
07:00 CEST 		ARGENX SE argenx to regain global rights to cusatuzumab 20103010 Biotechnology Other subject
01 Jun 2021
10:01 CEST 		ARGENX SE argenx Appoints Karl Gubitz as Chief Financial Officer 20103010 Biotechnology Other subject
01 Jun 2021
07:00 CEST 		ARGENX SE argenx to Present at Upcoming Investor Conferences 20103010 Biotechnology Other subject